319 related items for PubMed ID: 16807617
1. Eprosartan mesylate effectively reduces systolic and diastolic blood pressure in a Canadian primary care setting.
Conter HS, McKay DW, Reiz RJ.
Can J Cardiol; 2004 Oct; 20 Suppl C():6C-10C. PubMed ID: 16807617
[Abstract] [Full Text] [Related]
2. The angiotensin receptor blocker eprosartan mesylate reduces pulse pressure in isolated systolic hypertension.
Teitelbaum I, Chilvers M, Reiz RJ.
Can J Cardiol; 2004 Oct; 20 Suppl C():11C-16C. PubMed ID: 16807618
[Abstract] [Full Text] [Related]
3. The effect of treatment with eprosartan on pulse pressure: factors predicting response.
de la Sierra A, Muñoz A, Arcos E, López JS, Relats J, ETAPA-2 study investigators.
Can J Cardiol; 2004 Oct; 20 Suppl C():17C-22C. PubMed ID: 16807619
[Abstract] [Full Text] [Related]
4. Once-daily eprosartan mesylate in the treatment of elderly patients with isolated systolic hypertension: data from a 13-week double-blind, placebo-controlled, parallel, multicenter study.
Punzi HA, Punzi CF.
J Hum Hypertens; 2004 Sep; 18(9):655-61. PubMed ID: 15042114
[Abstract] [Full Text] [Related]
5. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
Levine B.
Curr Med Res Opin; 2001 Sep; 17(1):8-17. PubMed ID: 11464450
[Abstract] [Full Text] [Related]
6.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
7. Efficacy of eprosartan in combination with HCTZ in patients with essential hypertension.
Sachse A, Verboom CN, Jäger B.
J Hum Hypertens; 2002 Mar; 16(3):169-76. PubMed ID: 11896506
[Abstract] [Full Text] [Related]
8. Effects of hypertension therapy based on eprosartan on systolic arterial blood pressure and cognitive function: primary results of the Observational Study on Cognitive function And Systolic Blood Pressure Reduction open-label study.
Hanon O, Berrou JP, Negre-Pages L, Goch JH, Nádházi Z, Petrella R, Sedefdjian A, Sévenier F, Shlyakhto EV, Pathak A.
J Hypertens; 2008 Aug; 26(8):1642-50. PubMed ID: 18622244
[Abstract] [Full Text] [Related]
9. Effectiveness and safety of eprosartan on pulse pressure for the treatment of hypertensive patients.
Robles NR, Martín-Agueda B, López-Muñoz F, Alamo C, Investigators of the ESTEPP Study.
Int J Clin Pract; 2005 Apr; 59(4):478-84. PubMed ID: 15853868
[Abstract] [Full Text] [Related]
10. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
Tytus RH, Burgess ED, Assouline L, Vanjaka A.
Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
[Abstract] [Full Text] [Related]
11.
; . PubMed ID:
[No Abstract] [Full Text] [Related]
12. Effect of eprosartan on cytoplasmic free calcium mobilization, platelet activation, and microparticle formation in hypertension.
Labiós M, Martínez M, Gabriel F, Guiral V, Munoz A, Aznar J.
Am J Hypertens; 2004 Sep; 17(9):757-63. PubMed ID: 15363816
[Abstract] [Full Text] [Related]
13. Effectiveness of eprosartan in diabetic hypertensive patients.
Robles NR, Martín-Agueda B, López-Muñoz F, Alamo C, Investigators of ESTEPP Study.
Eur J Intern Med; 2008 Jan; 19(1):27-31. PubMed ID: 18206598
[Abstract] [Full Text] [Related]
14. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
[Abstract] [Full Text] [Related]
15. A randomized, comparative study evaluating the efficacy and tolerability of losartan-low dose chlorthalidone (6.25 mg) combination with losartan-hydrochlorothiazide (12.5 mg) combination in Indian patients with mild-to-moderate essential hypertension.
Pareek A, Basavanagowdappa H, Zawar S, Kumar A, Chandurkar N.
Expert Opin Pharmacother; 2009 Jul; 10(10):1529-36. PubMed ID: 19514864
[Abstract] [Full Text] [Related]
16. Assessment of efficacy, safety and tolerability of fixed dose combination of telmisartan 40mg and hydrochlorothiazide 12.5mg in adult Indian patients with mild to moderate hypertension.
Jayaram S, Lahoti S, Chandrasekharan S, Ganesan R, Muralidharan RS, Mishra AB, Sodhi SS, Rajadhyaksha GC, Jain SD, Kadam GS, Gawde A, Desai A.
J Indian Med Assoc; 2004 Sep; 102(9):525-7. PubMed ID: 15887845
[Abstract] [Full Text] [Related]
17. Atenolol and eprosartan: differential effects on central blood pressure and aortic pulse wave velocity.
Dhakam Z, McEniery CM, Yasmin, Cockcroft JR, Brown MJ, Wilkinson IB.
Am J Hypertens; 2006 Feb; 19(2):214-9. PubMed ID: 16448896
[Abstract] [Full Text] [Related]
18. Effect and tolerability of felodipine ER (Feloten) in the treatment of hypertension assessed by office blood pressure and home blood pressure.
Thongsri T.
J Med Assoc Thai; 2008 May; 91(5):633-40. PubMed ID: 18672624
[Abstract] [Full Text] [Related]
19. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R.
Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
[Abstract] [Full Text] [Related]
20. Safety and tolerability of eprosartan in combination with hydrochlorothiazide.
Böhm M, Sachse A.
Drug Saf; 2002 Apr; 25(8):599-611. PubMed ID: 12113644
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
